Elbasvir/Grazoprevir and Sofosbuvir for HCV Genotype 3 Infection With Compensated Cirrhosis: A Randomized Trial

Hepatology - United States
doi 10.1002/hep.29852
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Short-Duration Treatment With Elbasvir/Grazoprevir and Sofosbuvir for Hepatitis C: A Randomized Trial

Hepatology
MedicineHepatology
2016English

The Efficacy and Safety of Elbasvir/Grazoprevir Treatment in HCV Genotype 1 Patients in Taiwan

Journal of Medical Virology
VirologyInfectious Diseases
2019English

Investigation of Pharmacokinetic Interactions Between Doravirine and Elbasvir/Grazoprevir and Ledipasvir/Sofosbuvir

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2019English

Effectiveness of Elbasvir/Grazoprevir in US Veterans With Chronic Hepatitis C Virus Genotype 1b Infection

Infectious Diseases and Therapy
Infectious DiseasesMicrobiology
2020English

An Integrated Analysis of Elbasvir/Grazoprevir in Korean Patients With Hepatitis C Virus Genotype 1b Infection

Clinical and molecular hepatology
MedicineHepatologyMolecular Biology
2019English

Randomised Clinical Trial: Sofosbuvir and Ledipasvir in Patients With Transfusion-Dependent Thalassaemia and HCV Genotype 1 or 4 Infection

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III Study

Hepatology
MedicineHepatology
2017English

Ledipasvir and Sofosbuvir for HCV-infection in Patients Coinfected With HBV

Antiviral Therapy
Infectious DiseasesPharmacology
2016English

Sofosbuvir, Peg Interferon & Ribavirin for Retreatment of HCV Genotype 1b Following Sofosbuvir and Ledipasvir Failure

Hepatology
MedicineHepatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy